Deep Track Capital »

Neumora Therapeutics shares owned by Deep Track Capital

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 1.0M 13.75

More positions owned by Deep Track Capital

Springworks Therapeutics (SWTX)
Amgen (AMGN)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Dyne Therapeutics (DYN)
Alnylam Pharmaceuticals (ALNY)
Guardant Health (GH)
Argenx Se Sponsored Adr (ARGX)
Intra Cellular Therapies Put Option (ITCI)
Intellia Therapeutics (NTLA)
Ocular Therapeutix (OCUL)
Dynavax Technologies Corp Com New (DVAX)
Axsome Therapeutics (AXSM)
Geron Corporation (GERN)
Autolus Therapeutics Spon Ads (AUTL)

View all positions for Deep Track Capital

Top funds holding Neumora Therapeutics

Softbank Group Corp
FMR
MIC Capital Management UK
T. Rowe Price Investment Management
ICONIQ Capital
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Artal Group
EcoR1 Capital
Johnson & Johnson
Citadel Advisors
Avidity Partners Management
OrbiMed Advisors
Deep Track Capital
BlackRock
Soros Capital Management

View all funds holding Neumora Therapeutics